Danaher Corporation $DHR Stake Lowered by Arthur M. Cohen & Associates LLC

Arthur M. Cohen & Associates LLC reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 4.0% during the 4th quarter, HoldingsChannel reports. The fund owned 152,666 shares of the conglomerate’s stock after selling 6,336 shares during the period. Danaher accounts for 5.7% of Arthur M. Cohen & Associates LLC’s holdings, making the stock its 6th biggest position. Arthur M. Cohen & Associates LLC’s holdings in Danaher were worth $34,950,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank Pictet & Cie Europe AG grew its holdings in shares of Danaher by 25.4% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after acquiring an additional 74,301 shares in the last quarter. Maxi Investments CY Ltd purchased a new position in shares of Danaher during the 3rd quarter valued at $3,251,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Defender Capital LLC. acquired a new stake in shares of Danaher in the 4th quarter valued at $35,715,000. Finally, CIBC Bancorp USA Inc. acquired a new stake in shares of Danaher in the 3rd quarter valued at $17,480,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Up 0.3%

Danaher stock opened at $181.57 on Wednesday. The firm has a market cap of $128.51 billion, a price-to-earnings ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a fifty day moving average price of $180.54 and a two-hundred day moving average price of $203.94.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.88 EPS. As a group, analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Barclays reduced their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. DZ Bank assumed coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Finally, Wells Fargo & Company reduced their price objective on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.